The estimated Net Worth of Kevin K Buckbee is at least $2.27 million dollars as of 28 February 2024. Kevin Buckbee owns over 5,144 units of Abbvie Inc stock worth over $1,358,822 and over the last few years Kevin sold ABBV stock worth over $908,688.
Kevin has made over 1 trades of the Abbvie Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Kevin sold 5,144 units of ABBV stock worth $908,688 on 28 February 2024.
The largest trade Kevin's ever made was selling 5,144 units of Abbvie Inc stock on 28 February 2024 worth over $908,688. On average, Kevin trades about 2,572 units every 0 days since 2024. As of 28 February 2024 Kevin still owns at least 6,983 units of Abbvie Inc stock.
You can see the complete history of Kevin Buckbee stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is North Waukegan Road, North Chicago, Lake County, Illinois, 60044, United States.
Over the last 12 years, insiders at Abbvie Inc have traded over $324,915,370 worth of Abbvie Inc stock and bought 214,015 units worth $14,446,494 . The most active insiders traders include Richard A Gonzalez, Frederick H Waddell et Glenn F Tilton. On average, Abbvie Inc executives and independent directors trade stock every 22 days with the average trade being worth of $7,529,855. The most recent stock trade was executed by Richard A Gonzalez on 5 August 2024, trading 66,500 units of ABBV stock currently worth $12,403,580.
AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.
Abbvie Inc executives and other stock owners filed with the SEC include: